To analyze how different levels of physical activity impact sexual outcomes and functioning specifically in cisgender women breast cancer survivors (BCSs) who are experiencing sexual dysfunction.
Key Findings:
Approximately 50% to 70% of women experience unfavorable changes to their sexual function due to breast cancer treatments.
Physical activity is known to improve overall health-related quality of life (HRQOL) for cancer survivors.
However, there is insufficient evidence on the benefits of exercise specifically for improving sexual function in BCSs.
Interpretation:
While physical activity is beneficial for overall health in cancer survivors, its specific impact on sexual function remains under-researched, highlighting a critical gap in the literature that needs to be addressed.
Limitations:
Variation in definitions of physical activity across studies.
Limited number of studies specifically addressing the relationship between physical activity and sexual function.
Potential biases in study selection or reporting.
Conclusion:
This integrative review highlights the need for further research to explore the effects of physical activity on sexual function in breast cancer survivors.
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
